EUROEYES (01846): Marcus Huascar Bracklo Transferred from Non-Executive Director to Executive Director

Stock News08-25

EUROEYES (01846) announced that Dr. Markus Braun has tendered his resignation as executive director and chief financial officer of the company due to his personal career development plans. He will also cease to serve as (i) the company's authorized representative under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited; and (ii) the company's authorized representative for receiving legal process documents and notices on behalf of the company in Hong Kong under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong), effective from September 14, 2025.

Mr. Marcus Huascar Bracklo has been transferred from non-executive director to executive director and appointed as chief financial officer, effective from September 14, 2025.

Effective from September 14, 2025: (a) Mr. Bracklo will no longer serve as a member of the audit committee; (b) Ms. Katherine Rong Xin, an independent non-executive director, will be appointed as a member of the audit committee; and (c) the audit committee will comprise Mr. Philip Duncan Wright (chairman), Mr. Hans Helmuth Hennig, and Ms. Xin.

Following his appointment and effective from September 14, 2025, Mr. Bracklo has been appointed as the authorized representative under the Listing Rules and the authorized representative and agent for service of process under the Companies Ordinance, filling the vacancy left by Dr. Braun.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment